Insider Transactions in Q4 2020 at Vertex Pharmaceuticals Inc (VRTX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 08
2020
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Bona fide gift
|
Indirect |
3,391
-31.52%
|
-
|
|
Nov 16
2020
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
38
-0.04%
|
$8,474
$223.45 P/Share
|
|
Nov 16
2020
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
7
-0.01%
|
$1,561
$223.29 P/Share
|
|
Nov 16
2020
|
Michael Parini EVP, Chief Adm, Leg & BD Off |
SELL
Open market or private sale
|
Direct |
91
-0.11%
|
$20,293
$223.51 P/Share
|
|
Nov 16
2020
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Open market or private sale
|
Direct |
42
-0.04%
|
$9,366
$223.57 P/Share
|
|
Nov 10
2020
|
Bruce I Sachs Director |
BUY
Open market or private purchase
|
Direct |
15,000
+18.83%
|
$3,255,000
$217.58 P/Share
|
|
Nov 04
2020
|
Michael Parini EVP, Chief Adm, Leg & BD Off |
SELL
Open market or private sale
|
Direct |
2,330
-1.65%
|
$507,940
$218.47 P/Share
|
|
Nov 04
2020
|
Michael Parini EVP, Chief Adm, Leg & BD Off |
BUY
Exercise of conversion of derivative security
|
Direct |
2,330
+7.4%
|
$200,380
$86.52 P/Share
|
|
Nov 03
2020
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
1,553
-1.07%
|
$329,236
$212.15 P/Share
|
|
Nov 03
2020
|
Stuart A Arbuckle EVP, COO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,553
+4.06%
|
$133,558
$86.52 P/Share
|
|
Oct 05
2020
|
Sangeeta N. Bhatia Director |
SELL
Open market or private sale
|
Direct |
10,516
-16.07%
|
$2,786,740
$265.69 P/Share
|
|
Oct 05
2020
|
Sangeeta N. Bhatia Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,729
+37.7%
|
$1,099,854
$126.68 P/Share
|